Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

The effectiveness of a self-efficacy enhancement program on health behaviors and clinical outcomes in people with metabolic syndrome: A quasi-experimental study in Thailand

Belitung Nursing Journal · Vol. 11 No. 4 (2025) · pp. 432–442

DOI
10.33546/bnj.3891
ISSN
2477-4073, 2528-181X
Published
2025-08-03
Publisher
Belitung Raya Publisher
Language
en
License
creativecommons.org/licenses/by-nc/4.0/

Abstract

Background: Metabolic syndrome (MetS) is a cluster of chronic conditions, including obesity, hyperglycemia, hypertension, and dyslipidemia, known to significantly increase the risk of cardiovascular diseases (CVDs). Effective interventions are needed to control the progression of MetS. Objective: This study aimed to determine the effectiveness of the Self-Efficacy Enhancement (SEE) program on health behaviors and clinical outcomes in individuals with Metabolic Syndrome (MetS). Methods: A quasi-experimental study with a two-group pretest-posttest design was conducted from September 2023 to January 2024. A purposive sample of 70 participants with MetS was recruited from two healthcare settings in Thailand. Participants were divided into two groups: an experimental group (n = 35) and a control group (n = 35). The experimental group received the SEE program based on Self-Efficacy Theory, while the control group received only routine nursing care for 12 weeks. Data were collected using a Personal Information questionnaire, a Health Behavior questionnaire, and clinical outcome assessments, including waist circumference (WC), blood pressure (BP), fasting plasma glucose (FPG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL cholesterol), and non-high-density lipoprotein cholesterol (non-HDL cholesterol), before and after the 12-week program. Data were analyzed using descriptive statistics, paired t-test, independent t-test, Wilcoxon signed-rank test, Mann-Whitney U-test, and ANCOVA. Results: Following the SEE program, the experimental group exhibited significant improvements in health behaviors (t = -12.830, p <0.001), a reduction in WC (t = 3.809, p <0.001), decreased SBP (z = -4.554, p <0.001) and DBP (t = -5.178, p <0.001), and an increase in HDL cholesterol (z= -3.193, p <0.001) compared to baseline measures. Furthermore, compared to the control group, the experimental group demonstrated significantly improved health behaviors (F = 193.86, p <0.001), lower WC (F = 19.58, p <0.001), lower FPG (F = 12.39, p <0.001), lower SBP (F = 25.04, p <0.001), lower DBP (F = 19.49, p <0.001), and lower non-HDL cholesterol (F = 8.49, p <0.01). Partial eta-squared (η²) indicated large effects for health behaviors, WC, FPG, SBP, DBP, TC, and HDL cholesterol; non-HDL cholesterol showed a medium effect. TC and HDL cholesterol showed no significant change after completing the program. Conclusion: The SEE program improved health behaviors and clinical outcomes, supporting its integration into standard MetS care in nursing practice. Through e-health, education, exercise guidance, role modeling, and support, the program can boost confidence in adopting healthier behaviors and reduce CVD risk. Future studies should explore extending the program duration, as the 12-week period may have been insufficient to observe significant changes. Trial Registry Number: Thai Clinical Trials Registry (TCTR20250218014)

Keywords

Collaboration network of the authors

7 authors · 10 co-authorship links · 1 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Mahidol University
  • Boromarajonani College of Nursing
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Piyaporn InthaphalanMahidol University2
Mira FajarinaMahidol University2
Uraiwan NonpanyaAffiliation unknown2
Nopparat SuanpanBoromarajonani College of Nursing1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210240190, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">The effectiveness of a self-efficacy enhancement program on health behaviors and clinical outcomes in people with metabolic syndrome: A quasi-experimental study in Thailand</dc:title><dc:creator>Chalermkwan Madsong</dc:creator><dc:creator>Jiraporn Lininger</dc:creator><dc:creator>Sangthong Terathongkum</dc:creator><dc:subject>metabolic syndrome</dc:subject><dc:subject>self-efficacy theory</dc:subject><dc:subject>health behavior</dc:subject><dc:subject>waist circumference</dc:subject><dc:subject>blood pressure</dc:subject><dc:subject>fasting blood glucose</dc:subject><dc:subject>dyslipidemia</dc:subject><dc:subject>HDL cholesterol</dc:subject><dc:subject>nursing interventions</dc:subject><dc:subject>cardiovascular risk</dc:subject><dc:subject>obesity</dc:subject><dc:subject>hypertension</dc:subject><dc:subject>hyperglycemia</dc:subject><dc:subject>Thailand</dc:subject><dc:subject>lifestyle modification</dc:subject><dc:subject>clinical outcomes</dc:subject><dc:subject>health education intervention</dc:subject><dc:description xml:lang="en">Background: Metabolic syndrome (MetS) is a cluster of chronic conditions, including obesity, hyperglycemia, hypertension, and dyslipidemia, known to significantly increase the risk of cardiovascular diseases (CVDs). Effective interventions are needed to control the progression of MetS. Objective: This study aimed to determine the effectiveness of the Self-Efficacy Enhancement (SEE) program on health behaviors and clinical outcomes in individuals with Metabolic Syndrome (MetS). Methods: A quasi-experimental study with a two-group pretest-posttest design was conducted from September 2023 to January 2024. A purposive sample of 70 participants with MetS was recruited from two healthcare settings in Thailand. Participants were divided into two groups: an experimental group (n = 35) and a control group (n = 35). The experimental group received the SEE program based on Self-Efficacy Theory, while the control group received only routine nursing care for 12 weeks. Data were collected using a Personal Information questionnaire, a Health Behavior questionnaire, and clinical outcome assessments, including waist circumference (WC), blood pressure (BP), fasting plasma glucose (FPG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL cholesterol), and non-high-density lipoprotein cholesterol (non-HDL cholesterol), before and after the 12-week program. Data were analyzed using descriptive statistics, paired t-test, independent t-test, Wilcoxon signed-rank test, Mann-Whitney U-test, and ANCOVA. Results: Following the SEE program, the experimental group exhibited significant improvements in health behaviors (t = -12.830, p &lt;0.001), a reduction in WC (t = 3.809, p &lt;0.001), decreased SBP (z = -4.554, p &lt;0.001) and DBP (t = -5.178, p &lt;0.001), and an increase in HDL cholesterol (z= -3.193, p &lt;0.001) compared to baseline measures. Furthermore, compared to the control group, the experimental group demonstrated significantly improved health behaviors (F = 193.86, p &lt;0.001), lower WC (F = 19.58, p &lt;0.001), lower FPG (F = 12.39, p &lt;0.001), lower SBP (F = 25.04, p &lt;0.001), lower DBP (F = 19.49, p &lt;0.001), and lower non-HDL cholesterol (F = 8.49, p &lt;0.01). Partial eta-squared (η²) indicated large effects for health behaviors, WC, FPG, SBP, DBP, TC, and HDL cholesterol; non-HDL cholesterol showed a medium effect. TC and HDL cholesterol showed no significant change after completing the program. Conclusion: The SEE program improved health behaviors and clinical outcomes, supporting its integration into standard MetS care in nursing practice. Through e-health, education, exercise guidance, role modeling, and support, the program can boost confidence in adopting healthier behaviors and reduce CVD risk. Future studies should explore extending the program duration, as the 12-week period may have been insufficient to observe significant changes. Trial Registry Number: Thai Clinical Trials Registry (TCTR20250218014)</dc:description><dc:publisher>Belitung Raya Publisher</dc:publisher><dc:date>2025-08-03</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://doi.org/10.33546/bnj.3891</dc:identifier><dc:identifier>10.33546/bnj.3891</dc:identifier><dc:source>Belitung Nursing Journal; Vol 11 No 4 (2025); 432-442</dc:source><dc:source>2477-4073</dc:source><dc:source>2528-181X</dc:source><dc:language>en</dc:language><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>